Toronto, ON, Dec. 12, 2019 (GLOBE NEWSWIRE) — The low survival rates of three of the four most lethal cancers in North America – pancreatic, colorectal and lung – are associated with KRAS mutations, a well-established cancer driver. Although there is an urgent need for…
Category: University of Toronto
LAB150 team at True Blue Expo
The True Blue Expo, held in March 2019, is the University of Toronto’s annual showcase of all things entrepreneurship and the capstone event of U of T Entrepreneurship Week. It was a great event and we are pleased that LAB150 garnered a lot of attention. Here’s…
Two New Projects: Cystic Fibrosis and Respiratory Syncytial Virus
Toronto, ON, Feb. 27, 2019 (GLOBE NEWSWIRE) — MaRS Innovation announced today the concurrent launch of two new LAB150 projects. These projects build on breakthroughs in disease-focused scientific research by prominent teams at The Hospital for Sick Children (SickKids) and the University of Toronto, both…